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Left atrial volumes and associated stroke subtypes
Quratulain Shaikh1, Bilal Ahmed2, Maryam Ahmed3, Jamal Hussain Mahar4, Masood Ahmad4, Ayesha Ahmed4,
Farzin Majeed1, Fariha Sadiq Ali5, Maria Khan1 and Ayeesha Kamran Kamal6,7*
Abstract
Background: Cardio embolism and cerebrovascular atherosclerosis are two major mechanisms of stroke. Studies
investigating associations between advanced echocardiographic parameters and stroke mechanisms are limited.
Methods: This study is a standardized review of 633 patients admitted to the stroke service of a tertiary care
hospital following a standardized stroke investigation and management pathway. Stroke subtypes were
characterized using the Causative Classification System, using the hospitals online radiologic archival system with
CCS certified stroke investigators. Patients with two mechanisms were excluded.
Results: Patients with cardioembolic stroke had a higher proportion of atrial fibrillation (p < 0.001), acute myocardial
infarction (p < 0.001) and ischemic heart disease (p < 0.001). On electrocardiogram (ECG) and transthoracic Echo
(TTE), patients with cardioembolic stroke had a greater atrial fibrillation (p < .00), left ventricular thrombus (p < .00),
left ventricular ejection fraction <30% (p < .00) and global hypokinesia (p < .00) Patients with cardioembolic stroke
had higher mean left atrial volume indices (LAVi) (p < 0.001), mean left ventricular mass indices (LVMi) (p < 0.05) and
mean left atrial diameters (LAD) (p < 0.05). At LAVi of 29–33 ml/m2, the risk of atherothrombotic stroke increased.
The risk of cardioembolic stroke increased with LAVi of 34 ml/m2 and above.
Conclusion: Left atrial volume indices may be linked to specific stroke phenotype. At mild increases in left atrial
dimensions, the risks of atherosclerotic stroke are high, and probably reflect hypertension as the unifying
mechanism. Further increases in left atrial dimensions shifts the risk towards cardioembolic stroke.
Background
Strokes constitute a global health epidemic and are the
leading cause of sustained disability [1]. Ischemic stroke
is a heterogeneous disease, the two main subtypes being
cardioembolic stroke and atherosclerotic stroke [2]. It is im-
portant to be able to identify these subtypes since thera-
peutic decisions for future prevention may differ [3]. The
underlying pathological processes are different in the two
subtypes; while advanced atherosclerotic stenosis is deemed
to be the major mechanism in atherothrombotic stroke, it
is the underlying cardiac abnormalities with relatively pre-
served architecture of blood vessels that eventually mani-
fests as cardioembolic strokes.
Atherosclerosis leading to hypertension is mirrored on
an echocardiogram as left ventricular hypertrophy [4].
Historically, echocardiographic predictors of vascular out-
come have focused on left ventricular morphology. Left
ventricular mass was found to predict stroke and coronary
artery disease [5]. In the Framingham Study, for each 50-g
increase in LVM, there was 1.5-fold increase in relative
risk for subsequent cardiovascular events [6]. Recent stud-
ies have reported left atrial diameter and left atrial volume
index to be associated with chronic hypertension and
stroke [7]. Although these values have helped in predicting
ischemic stroke their association with specific stroke sub-
types has not been established.
We hypothesized that patients who present with car-
dioembolic stroke have greater Left Atrial Diameters
(LAD), increased Left Atrial Volume Indices (LAVi) and
Left Ventricular Mass (LVM) when compared to those
with atherosclerotic stroke. We investigated the relation-
ship if any, between atrial predictors of stroke subtype
on routine post stroke transthoracic echocardiograms.
* Correspondence: ayeesha.kamal@aku.edu
6The International Cerebrovascular Translational Clinical Research Training
Program, Stroke Services, Aga Khan University, Karachi, Pakistan
7Stroke Services, Section of Neurology, Department of Medicine, Stroke
Fellowship Program, International Cerebrovascular Translational Clinical
Research Training Program, Aga Khan University Hospital, Stadium Road, 74800,
Karachi, Pakistan
Full list of author information is available at the end of the article
© 2013 Shaikh et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Shaikh et al. BMC Neurology 2013, 13:149
http://www.biomedcentral.com/1471-2377/13/149
Methods
The Aga Khan University Hospital is a JCIA (Joint Com-
mission International Accreditation) accredited tertiary
care hospital in Karachi, Pakistan. Stroke care is deliv-
ered through a 24-hour on-call neurology team with a
stroke service on call for hyperacute stroke with a 5 bed
specialized stroke unit and a full range of ancillary ser-
vices. As a standard of care, all admitted stroke patients
are evaluated by a consultant neurologist and undergo
stroke workup that includes neuroimaging via MRI and
MRA, electrocardiogram (ECG), transthoracic echocardiog-
raphy (TTE), Carotid Doppler Sonography and Biochemical
workup such as serum glucose, lipid profile, blood urea ni-
trogen and serum creatinine. These are standardized inves-
tigations that are conducted on every admission and ensure
homogeneity of evaluation. All these scans and echocardio-
grams are accessible via the hospital online database that
details all investigations for these patients. In addition, all
admissions are encoded for stroke diagnosis through a hos-
pital wide ICD-9 coding system allowing identification of
all admissions.
This set up enabled a comprehensive review of all adult
stroke patients admitted to this service from July 2005 to
December 2010. There were 633 patients admitted, identi-
fied as suffering from ischemic stroke through the ICD-9
code with the assistance of medical records. Patients with
evidence of hemorrhagic stroke, subarachnoid hemorrhage,
and those with hematologic, neoplastic, infectious, iatro-
genic or inflammatory conditions associated with stroke
were excluded because the pathophysiology and natural
course of these causes differ from atherosclerotic ischemic
stroke. Patients with stroke due to any other subtype e.g.
Cryptogenic stroke, stroke due to known hypercoagulable
state, dissection were excluded from this review. Add-
itionally, patients with more than one competing diag-
nosis were excluded.
Data was reviewed for demographic characteristics and
electrocardiographic and echocardiographic data was also
recorded on a predesigned structured questionnaire. This
was developed in conjunction with cardiological input.
Demographic variables included age and gender, medical
variables including height, weight, history or evidence of
diabetes mellitus, hypertension, dyslipidemia, history of is-
chemic heart disease, prior stroke, and history of atrial fib-
rillation, congestive cardiac failure and tobacco use were
recorded. ECGs were analyzed for evidence of atrial fibrilla-
tion. Echocardiographic evidence was documented for the
presence of left atrial thrombus, left ventricular thrombus,
presence of any vegetation, global segmental hypokinesia,
left ventricular ejection fraction less than 30%, measure-
ments were recorded for left atrial diameter (LAD) which
was measured in antero posterior (AP) linear dimension
obtained from the parasternal long axis view, at Left Ven-
tricular end systole (when left atrium is at the maximum
volume), left atrial volume index (LAVi), left ventricular
diameter in diastole (LVD), posterior left ventricular wall
thickness (PWT), and interventricular septal thickness
(IVST). Left Ventricular mass (LVM) was calculated using
the guidelines from American Society of Echocardiography
(ASE) and indexed for body surface area (LVMi) as rec-
ommended for reference in population. Reference values
for LAD, LAVi and LVMi in males and females were de-
rived from Guidelines from the American Society of Echo-
cardiography [8].
Furthermore for left atrial measures, since single axis
measurement is unreliable when atrial dilation is non-
uniform, in our laboratory we actually measure both. i.e.
the LA diameter in AP length and also the atrial volume
which is measured by using area-length (L) method
using Apical 4 chamber view (A1) and apical 2 chamber
view (A2) at ventricular end systole. The information is
put in the formula 0.85 (A1 × A2) divided by L for the
atrial volume and indexed to Body Surface Area (BSA)
giving us the left atrial volume index (LAVi).
Strokes were classified using the Causative Classifica-
tion of Stroke by neurologists who were trained in stroke
diagnosis and ran a stroke clinic [9]. In addition, mag-
netic resonance imaging and carotid doppler scans read
by trained neuroradiologists were utilized for this classi-
fication. The stroke classifying personnel were trained
and certified in this technique before undertaking this
review. This classification team did not have access to
the exact advanced echocardiographic measures that are
reported in this study during the time of stroke classifi-
cation. The CCS system is an online system where data
is entered into a computerized system and it assists
in the correct mechanistic diagnosis, with a level of
confidence assigned to the mechanism as probable, pos-
sible or evident, we included patients in the cardio-
embolic and atherosclerotic stroke category when any of
these levels were assigned, and there were no competing
mechanisms.
After entering the data for stroke classification, demo-
graphic variables and echocardiographic data, simple fre-
quencies were run and comparisons were performed. Data
was entered centrally with the echocardiography team and
classification team both unaware of any emerging trends
till the data entry was complete.
For the purpose of this comparative analysis those with
evident, possible and probable Cardioembolic Strokes were
compared with patients with stroke due to atherosclerotic
mechanisms (Large artery, ICAD -IntraCranial Athero-
sclerotic Disease, ECAD-ExtraCranial Atherosclerotic Dis-
ease and Small vessel strokes).
The study was approved by the Ethical Review Commit-
tee of the Aga Khan University through approval number
1660-Neu-ERC-2010 under exemption category as it is a
detailed review.
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Statistical analysis
Data were analyzed through SPSS 19, and reported as
mean ± SD for continuous variables and proportions and
percentages for categorical data. Comparisons between
groups were done by the unpaired Student’s t-test and Chi-
square test respectively. P value less than 0.05 was consid-
ered significant. Normality of the data was assessed by
Kolmogorov-Smirnov statistic.
Results
There were 633 patients included in this study. All pa-
tients had undergone ECG, MRI, DWI, MRA, TTE and
carotid doppler. Of these 60% were in the atherosclerotic
ischemic stroke group and 40% were cardioembolic is-
chemic stroke group. 64% of the patients were male. The
median age was 61 years. According to the Asia Pacific
criteria for obesity 56% of the patients were obese [10].
79% of the patients were hypertensive and 22% had a
prior stroke. 17% were using tobacco (Table 1).
Patients with cardioembolic stroke had a significantly
higher prevalence of atrial fibrillation (p < .00), acute myo-
cardial infarction (p < .00) and history of ischemic heart
disease (p < .00). They were more prone to develop acute
myocardial infarction (MI) during hospital stay and had
significantly higher prevalence of previous myocardial in-
farction. Moreover the history of cardiac valve replace-
ment was significantly higher in the cardioembolic stroke
sub population. Rest of the demographic variables was
comparable in the two groups.
ECG and TTE data revealed that cardioembolic stroke
group had higher prevalence of atrial fibrillation (p < .00),
left ventricular thrombus (p < .00), left ventricular ejection
fraction < 30% (p < .00) and global ventricular hypokinesia
(p < .00) (Table 2).
Patients with cardioembolic stroke had higher mean
left atrial volume indices (LAVi) (p < .00), mean left atrial
diameters (LAD) (p < .05) and left ventricular mass indi-
ces (LVMi) (< .05) than the atherothrombotic stroke pa-
tients (Table 3).
At LAVi of 29–33 ml/m2, the risk of atherothrombotic
stroke increased. The risk of cardioembolic stroke in-
creased with LAVi of 34 ml/m2 and above. Hence the
observation was that the risk of cardioembolic stroke in-
creased with increasing left atrial volume indices in the
moderate to severely enlarged category. At mild increase
in left atrial diameter and left atrial volume index the
risk of atherosclerotic stroke was increased (Table 4).
Discussion
Although transthoracic echo is a routine investigation in
stroke patients, its value for predicting stroke sub typing
has been relatively limited as all the data contained in
these studies is often inadequately utilized by neurolo-
gists. In another study from this region, the yield for
predicting stroke subtype was reported to be approxi-
mately 15% for cardioembolic sources of ischemic stroke
[11]. We believe that this is the first detailed report on
the putative mechanisms and advanced echocardiographic
associations of stroke subtypes, which report that atrial
dilation initially associates with atherosclerotic strokes and
later with further increases, associates with cardioembolism.
Conventionally, echocardiographic measures have focused
Table 1 Baseline demographic characteristics of patients by stroke subtype
All stroke patients Cardioembolic stroke group Atherosclerotic stroke group P value
N 633 N 256 (40) N 377 (59.9)
Gender men/women 406 (64) 163 (40) 243 (59.9) 0.45
BMI obese* 356 (56.2) 142 (40) 214 (60) 0.76
Ischemic heart disease 142 (22.4) 77 (54.2) 65 (45.8) 0.00
Previous MI 47 (7.4) 25 (53.2) 22 (46.8) 0.04
Acute MI 18 (2.8) 13 (72.2) 5 (27.8) < .00
Type II DM 325 (51.3) 132 (40.6) 193 (59.4) 0.49
Hypertension 500 (79) 201 (40.2) 299 (59.8) 0.44
Cardiac valve prosthetic 9 (1.4) 7 (77.8) 2 (22.2) 0.02
Atrial fibrillation 51 (8.1) 40 (78.4) 11 (21.6) 0.00
Valvular heart disease 5 (0.8) 4 (80) 1 (20) 0.09
Dyslipidemia 336 (53) 128 (38) 208 (61.9) 0.11
Tobacco use 109 (16.9) 45 (42) 62 (57.9) 0.39
Prior stroke 145 (22.9) 57 (39.3) 88 (60.7) 0.41
Heart failure 57 (1.1) 5 (71.4) 2 (28.6) 0.09
*Asia Pacific Criteria for obesity as applicable to South Asians is used to define this population.
Legend: Patients with cardioembolism have more ischemic heart disease, heart failure, valvular heart disease and replacements, atrial fibrillation as compared to
patients with atherosclerotic stroke.
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on ventricular predictors of cardioembolism and have failed
to appreciate atrial predictors. Data deeming atrial fibrilla-
tion and atrial flutter as risk factors for cardioembolic
stroke has been validated by many investigators Other well
appreciated and mostly ventricular risk factors for cardio-
embolic stroke that have been identified include acute myo-
cardial infarction, history of prior MI, history of cardiac
valve replacement and history of ischemic heart disease that
affect valvular parameters or ventricular hypokinesia.
There is adequate data reporting left atrial volume index
(LAVi) to be a better measure of left atrial dilatation as
compared to left atrial diameter, providing a more accur-
ate assessment of left atrial size than conventional M-
mode LAD [7-9]. LAD is a single-axis measurement based
on the antero-posterior length of the left atrium. When
left atrial enlargement is not uniform, LAD will therefore,
not reflect left atrial size accurately. Recent guidelines
from the American Society of Echocardiography (ASE)
have recommended LAVi measurement be used for left
atrial size quantification in clinical practice [8]. Left atrial
size has been investigated as a link to stroke and it has
been found that an association between left atrial diameter
and left atrial volume indexed to body surface area and is-
chemic stroke exists [12-15]. This association is irrespect-
ive of the presence or absence of hypertension as a risk
factor. This data however does not categorize the inde-
pendent risk associated with stroke subtypes, as patho-
logical determinants of cardioembolic stroke depend on
cardiac morphology more strongly than atherothrombotic
stroke do. Our data shows a statistically significant associ-
ation of mean LAVi and LAD with cardioembolic stroke.
This is an important resolution as these echocardiographic
determinants may predict the risk of cardioembolic stroke
and specific interventions could be offered to this subset
of patients, where the diagnosis isn’t apparent. Further in-
vestigation for atrial fibrillation (associated with atrial dila-
tion) via Holter and a TEE could be considered in lieu of
clinically important decisions pertaining to anticoagulation.
Use of left atrial appendage velocity measurement on TTE
and or TEE may be a useful surrogate marker of altered
Table 2 Yield of conventional electrocardiographic and transthoracic echocardiographic evaluation of patients by
stroke subtype
Finding on ECG#/
Echocardiogram*
All stroke patients Cardioembolic stroke group Atherosclerotic stroke group P value
n (%) n (%) n (%)
Atrial fibrillation# 56 (8.8) 39 (69.6) 17 (30.4) < .00
Atrial flutter# 3 (0.5) 3 (1.2) 0 (0) 0.06
Evidence of prior MI# 37 (95.8) 19 (951.4) 18 (48.6) 0.11
First degree AV block# 46 (7.3) 22 (47.8) 24 (52.2) 0.18
Left ventricular thrombus* 15 (2.4) 12 (80) 3 (20) < .00
Left atrial thrombus* 1 (0.2) 0 (0) 1 (0.3) 0.59
Vegetation* 1 (0.2) 0 (0) 1 (0.3) 0.59
LVEF < 30%* 68 (10.7) 56 (82.4) 12 (17.6) < .00
Global segmental hypokinesia* 108 (17.1) 74 (68.5) 34 (31.5) < .00
Legend: Atrial flutter and fibrillation on 12- Lead EKG were clearly helpful, although low yield overall at 8.8% of the entire study group (56/633), Obvious
echocardiographic predictors mostly ventricular based like thrombi, vegetations, EF reduction, and hypokinesia were actually also low yield.
# Findings on ECG.
* Findings on Echo cardiogram.
Table 3 Trends of left atrial enlargement and stroke subtypes
LA diameter males LA diameter females LAVi males LAVi females
Cardioembolic stroke None 138 (85) 65 (70) 54 (52) 19 (31)
Mild 9 (6) 8 (9) 18 (17.5) 16 (26)
Moderate 8 (5) 11 (12) 14 (14) 11 (18)
Severe 7 (4) 9 (10) 17 (16.5) 16 (25.5)
Atherothrombotic stroke None 206 (84) 109 (81) 87 (52) 39 (44)
Mild 28 (11.5) 14 (10) 42 (25) 25 (28)
Moderate 8 (3) 3 (2) 25 (15) 14 (16)
Severe 2 (0.8) 8 (6) 13 (8) 10 (11)
P value < .020 < .016 < .105 < .098
Legends: LA Diameter: Left atrial Diameter.
LAVi: Left atrial volume index.
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appendage function. It could potentially be incorporated in
assessing risk of thrombus formation. It may thus, assist
secondary prevention decisions, in absence of documented
LAA clot or atrial fibrillation. However, these tests are
technically demanding in stroke patients with impaired
swallowing mechanisms and cognitive impairment.
We must clarify that LAA velocity on TTE is mea-
sured by using non-conventional views and has been val-
idated by only a few studies using TEE which is the gold
standard. TTE is further limited in good image acquisi-
tion in obese, very thin or COPD patients [16-19].
Of particular interest, was the trend in left atrial en-
largement and its predilection for the stroke subtype. It
was observed that at mild increases in left atrial volume
indices, the risk was higher for atherothrombotic strokes
but as the left atrial volume index rose higher and en-
tered the moderate to severe category the risk shifted to-
wards the cardioembolic subtype. We hypothesize that
these atherosclerotic stroke patients have left atrial enlarge-
ment mediated through hypertension. This may also ex-
plain the observation that some patients present with
cardioembolic strokes but often have underlying athero-
sclerotic intracranial disease thus displaying a mixed patho-
genic mechanism of stroke. However this observation is
speculative and requires further investigation via longitu-
dinal investigations in these patients that may involve serial
echocardiograms and prolonged arrhythmia monitoring.
With respect to ventricular parameters, poor left ven-
tricular ejection fraction and global left ventricular hypo-
kinesia are direct measures of a poor cardiac reserve and
cardiac failure. These conditions lead to vascular stasis and
the propensity to thrombus formation in the left ventricle.
As a result we saw a higher prevalence of presence of left
ventricular thrombus in our patients with varying ventricu-
lar dysfunctions thus showing a predilection for develop-
ment of cardioembolic stroke. Increased left ventricular
mass indexed to body surface area is a measure of the
left ventricular hypertrophy as a consequence of under-
lying hypertension. Our data suggests that patients with
cardioembolic ischemic strokes have significantly higher
LVMi than the atherosclerotic stroke patients. Interest-
ingly the left atrial diameter index and left ventricular
mass index in both sexes, although within normal ranges,
were also significantly higher in the cardioembolic stroke
group than the atherosclerotic stroke group.
The strengths of this study include its robust and
complete methods of evaluation and case ascertainment,
homogeneity of review, and availability of data on all pa-
tients. CCS classification been used as the stroke category
classification with experienced investigators and was de-
tailed and blinded to advanced/ cardiologic parameters.
There are few investigations that link these advanced pa-
rameters to stroke subtypes and we demonstrate that we
can use these data to assist in understanding stroke mech-
anisms in our patients, or further our investigations to en-
sure that atrial mediated events are not the proximate
cause of stroke in our patients. Our study has limitations,
this is a retrospective design, a prospective longitudinal as-
sessment would be ideal. In those patients that had ath-
erosclerosis plus and embolic looking stroke with high
atrial size, we did not routinely check for atrial fibrillation
via prolonged monitoring beyond the hospital stay, this
would further cement our preliminary observations, clas-
sification was done by two neurologists with one arbitra-
tion in case of discordant coding to resolve issues, but a
single observation would have minimized the inter obser-
ver bias. Although attempts at standardized classification
have been made, it must be appreciated that stroke classi-
fication isn’t absolute and patients may be have more than
one stroke subtype responsible for their event. Further-
more, atrial size increases with higher prevalence of atrial
fibrillation this may explain the tilt that we have observed
towards cardioembolism. We must add that these are pre-
liminary observations and will require further analysis of
association. Lastly, since this is a South Asian population,
it has a higher number of patients with atherosclerotic
mechanisms mainly intracranial atherosclerosis which al-
though a similar demographic to China, Japan, South East
Asia, Hispanics and Blacks does not exactly mirror the
stroke subtype distribution of the Western population and
these ethnic variations must be kept in mind as these data
may not represent global associations.
We suggest that further prospective observational studies
studying the relationship between atrial parameters and
stroke subtypes should be performed as they provide useful
insight into unraveling mechanisms of strokes in individual
patients especially those with perhaps multiple overlapping
proximate causes of stroke, with increasing atrial dilation.
This insight will eventually contribute to better and effect-
ive secondary prevention in individual patients.
Table 4 Distribution of left atrial enlargement and left
ventricular hypertrophy by stroke subtype
Mean Values Cardioembolic
stroke
Atherothrombotic
stroke
P value
LAVi* 33.4 30 < .00
ml/m2
LAD# 36 35 < .05
mm
LVMiß 80.9 76 < .05
gm/m2
*LAVi: Left atrial volume index, left atrial diameter and left atrial volume
indexed to body surface area is a better measure when left atrial dilation is
non- uniform.
#LAD: Left atrial dilation is a single-axis measurement based on the
antero-posterior length of the left atrium, may be unreliable when dilation
is non-uniform.
ß LVMi: Left ventricular mass index, Left ventricular mass indexed to body
surface area is a measure of the left ventricular hypertrophy.
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Conclusion
Left atrial size may be associated with specific stroke
phenotype, further studies investigating atrial parame-
ters on echo cardiogram and stroke subtypes are needed.
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